- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Iris Melanoma in Austria
Total 320 results
-
Eisai Inc.CompletedStage IV Melanoma | Unresectable Stage IIIUnited States, United Kingdom, Australia, Germany
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingMalignant Melanoma Stage IIIUnited States, Netherlands, Australia
-
Melanoma and Skin Cancer Trials LimitedNorfolk and Norwich University Hospitals NHS Foundation Trust; Canadian Cancer... and other collaboratorsRecruitingCutaneous Melanoma, Stage IIUnited States, Canada, United Kingdom, Australia, Italy, Sweden, Netherlands, New Zealand
-
Array BioPharmaTerminatedMelanomaCanada, Spain, Australia, Switzerland, Germany, United States
-
Southwest Oncology GroupNational Cancer Institute (NCI); Eastern Cooperative Oncology Group; Children... and other collaboratorsCompletedMelanoma (Skin)United States, Australia
-
Bristol-Myers SquibbCompletedMelanomaItaly, France, Spain, Australia
-
GlaxoSmithKlineCompletedMelanomaFrance, Italy, Germany, Netherlands, Switzerland, United Kingdom, Austria, Australia
-
Aciont IncNational Eye Institute (NEI)CompletedNon-Infectious Anterior UveitisUnited States
-
IDEAYA BiosciencesRecruitingMetastatic Uveal MelanomaUnited States, Canada, Israel, Spain, Australia, Germany, France, Italy, United Kingdom, Netherlands, Belgium, Poland, Switzerland
-
AmgenMerck Sharp & Dohme LLCTerminatedMelanomaUnited States, Finland, France, Germany, Italy, Canada, Czechia, Poland, Switzerland, Korea, Republic of, Russian Federation, United Kingdom, Australia, Netherlands, Spain, Austria, Belgium, Hungary, Portugal, Greece, South Africa
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Cutaneous Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Recurrent Cutaneous Melanoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Recurrent Mucosal Melanoma | Metastatic Mucosal Melanoma | Non-Cutaneous Melanoma | Metastatic Non-Cutaneous Melanoma | Recurrent Non-Cutaneous...United States, Canada, Ireland
-
Bristol-Myers SquibbCompletedMelanomaBelgium, Brazil, United States, Canada, Spain, Greece, France, United Kingdom, Australia, Italy, Austria, Switzerland, Germany, Israel, Russian Federation, Romania, Czechia, Poland, New Zealand
-
GlaxoSmithKlineCompletedMelanomaUnited States, Italy, United Kingdom, France, Sweden, Germany, Poland, Australia, Belgium, Austria, Canada, Czechia, Greece, Russian Federation, Ukraine, Norway, Switzerland, New Zealand, Argentina
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Germany, Singapore, Italy, Australia, Netherlands, Sweden, Spain, Canada, Switzerland, Argentina, Brazil, China
-
Bristol-Myers SquibbActive, not recruitingMelanomaItaly, United States, Germany, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Denmark, Finland, France, Greece, Israel, Mexico, New Zealand, Norway, Poland, Romania, Russian Federation, Spain, Sweden, United Kingdom
-
PlexxikonRoche Pharma AGCompletedColorectal Carcinoma | Malignant MelanomaUnited States, Australia
-
Eli Lilly and CompanyTerminatedMelanomaUnited States, Italy, Australia, Spain, France, Netherlands, United Kingdom, Austria, Poland, Germany, Belgium, Taiwan, Canada, Finland, Israel, Korea, Republic of, Norway, Sweden
-
Canadian Cancer Trials GroupMelanoma and Skin Cancer Trials LimitedRecruitingUnresectable/Metastatic MelanomaCanada, Australia
-
Bristol-Myers SquibbActive, not recruitingMelanomaUnited States, Italy, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia, Denmark, Finland, France, Germany, Greece, Israel, Mexico, Norway, Romania, Spain, Sweden, Switzerland, United Kingdom
-
Bristol-Myers SquibbNektar TherapeuticsCompletedMelanomaCanada, Australia, France, Italy, Brazil, United States, Argentina, Austria, Belgium, Chile, Czechia, Finland, Germany, Greece, Ireland, Israel, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Spain, Sweden and more
-
Bristol-Myers SquibbCompletedMelanomaCanada, Australia, Germany, Italy, Poland, France, Denmark, Argentina, Chile, Spain, Norway, Israel, Sweden, Mexico, Greece, Finland
-
Bristol-Myers SquibbMedarexCompletedMelanomaUnited States, Spain, Austria, Italy, Sweden, Russian Federation, Ukraine, Finland, Norway, Poland
-
PfizerCompletedMetastatic or Unresectable Cutaneous MelanomaUnited States, Spain, Canada, Italy, United Kingdom, Germany, Korea, Republic of, France, Australia, Czechia, Russian Federation, Turkey, Israel, Netherlands, Greece, Hungary, Japan, Portugal, Argentina, Austria, Belgium, Brazil, Po... and more
-
Pierre Fabre MedicamentEuropean Organisation for Research and Treatment of Cancer - EORTCActive, not recruitingMelanomaSpain, Canada, Hungary, Italy, Belgium, Netherlands, Australia, Czechia, Greece, Brazil, Portugal, Serbia, Sweden, Norway, Germany, Argentina, Romania, Poland, United Kingdom, Austria, Switzerland, France, South Africa
-
Medical University of GrazCompleted
-
GlaxoSmithKlineTerminatedMelanoma and Brain MetastasesUnited States, Australia
-
Medical University of GrazCompleted
-
GlaxoSmithKlineCompletedCancerAustralia, Spain, United States, Germany, Poland, Italy, Canada, Ireland, Hungary, Russian Federation, Netherlands, France
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, Belgium, Canada, Spain, United Kingdom, Netherlands, Argentina, Australia, Austria, Brazil, Czechia, Denmark, France, Germany, Greece, Israel, Italy, Japan, New Zealand, Norway, Poland, Russian Federation, Sweden, Switz... and more
-
AstraZenecaCompletedMelanomaUnited States, Italy, Spain, Sweden, Belgium, Canada, Poland, Switzerland, France, Russian Federation, United Kingdom, Australia, Argentina, Germany, Netherlands, Israel, South Africa, Austria, Greece, Mexico, Slovakia
-
Incyte CorporationActive, not recruiting
-
Genta IncorporatedCompletedMelanomaUnited States, France, United Kingdom, Spain, Switzerland, Australia, Canada, Germany, Poland, Italy, Austria, Czech Republic
-
Novartis PharmaceuticalsCompletedMelanomaUnited States, United Kingdom, Austria, Belgium, Hungary, Canada, Netherlands, Argentina, Australia, Brazil, Czechia, Denmark, France, Germany, Israel, Italy, Norway, Poland, Russian Federation, Spain, Switzerland, Taiwan, Korea, Republic... and more
-
Novartis PharmaceuticalsCompletedMelanomaCanada, Spain, United Kingdom, Netherlands, United States, Argentina, Australia, France, Germany, Greece, Italy, Russian Federation, Sweden, Ukraine
-
BayerAmgenCompletedMelanomaUnited States, Canada, Germany, France, United Kingdom, Australia, Netherlands
-
Bristol-Myers SquibbActive, not recruitingMelanomaItaly, Poland, United States, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Greece, Netherlands, Norway, Romania, Spain, Switzerland, United Kingdom, Sweden
-
Agenus Inc.CompletedMalignant MelanomaUnited States, Australia, Poland, Ukraine, United Kingdom, Russian Federation, Hungary, Italy, Sweden
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaUnited States, Australia, France, Israel, Italy, Switzerland
-
Bristol-Myers SquibbCompletedMelanomaSouth Africa, United States, Spain, France, Italy, Belgium, Austria, Israel, Germany, Norway, Canada, Brazil, Poland, Denmark, Czech Republic, Russian Federation, Ukraine, Argentina
-
Ascentage Pharma Group Inc.Merck Sharp & Dohme LLCRecruitingMelanoma | P53 Mutation | Uveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Malignant Peripheral Nerve Sheath Tumors | MPNST | Unresectable or Metastatic Melanoma or Advanced Solid Tumors | MDM2 Gene MutationUnited States, Australia
-
SanofiActive, not recruitingMalignant Melanoma | Squamous Cell Carcinoma of SkinGermany, Spain, France, Chile, United States, Australia, Italy
-
Medical University of ViennaEnrolling by invitationGlaucoma | Cataract | Meibomian Gland Dysfunction | Aniridia | Corneal Transplantation | Acanthamoeba Keratitis | Demodicosis | Conjunctival PathologiesAustria
-
Incyte CorporationMerck Sharp & Dohme LLCCompletedMelanomaUnited States, France, Italy, United Kingdom, Spain, Belgium, Israel, Mexico, Japan, Canada, Netherlands, Sweden, Korea, Republic of, Australia, Russian Federation, Chile, Germany, Poland, Ireland, New Zealand, Denmark, Switzerland, South Africa
-
Medical University of GrazCompleted
-
GlaxoSmithKlineTerminatedMelanomaUnited States, Australia, Spain, Taiwan, Bulgaria, Estonia, Germany, Belgium, France, Sweden, Israel, Poland, Italy, Czechia, Switzerland, Korea, Republic of, Ireland, Canada, Argentina, Netherlands, Russian Federation, Ukraine, Aus... and more
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaUnited States, Australia, France, Israel, Italy, Switzerland
-
Exact Sciences CorporationTerminatedMelanomaUnited States
-
Bristol-Myers SquibbCompletedMelanomaUnited States, Australia, Belgium, Italy, Poland, Spain, United Kingdom
-
Bristol-Myers SquibbCompletedMelanomaBrazil, Chile, United States, Ireland, Italy, Spain, Argentina, Australia, Canada, France, Mexico, New Zealand, Poland, Romania
-
CelgeneICON Clinical ResearchCompletedMelanoma | Neoplasm MetastasisAustralia, United Kingdom, Ukraine, Germany, Estonia, Latvia, Lithuania, Netherlands, South Africa